BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Ariosa Diagnostics, Inc. Announces Partnership With The Doctors Laboratory (TDL) to Distribute the Harmony™ Prenatal Test in the UK


1/9/2013 9:35:00 AM

SAN JOSE, Calif., Jan. 9, 2013 /PRNewswire/ -- Ariosa Diagnostics is pleased to announce that they have entered into a mutual partnership with The Doctors Laboratory, in London, to promote and distribute the Harmony Prenatal Test. Under the terms of the agreement, TDL will offer the Harmony test through their reference laboratory services to doctors and their pregnant patients.

(Logo: http://photos.prnewswire.com/prnh/20121203/NE22396LOGO )
(Logo: http://photos.prnewswire.com/prnh/20130109/NE39514LOGO )

Ken Song, M.D., CEO of Ariosa Diagnostics, said, "We are pleased to have partnered with TDL Genetics to offer the Harmony test. The quality of service that TDL offers aligns with our goal to responsibly introduce our test in markets outside of North America."

Dr. Lisa Levett, director of TDL Genetics, said: "Non-invasive prenatal testing is one of the most exciting and important developments in this field in the last 50 years. Our laboratory has always been at the forefront of the latest prenatal diagnostic technology for example, we developed the first rapid PCR-based prenatal Down syndrome test, Amnio-PCR or qf-PCR. We are delighted to be working with Ariosa to bring the non-invasive Harmony Prenatal Test to the many doctors and hospitals we work with in the UK and overseas."

About Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com.

About The Doctors Laboratory

The Doctors Laboratory (TDL) is the largest independent clinical pathology organisation in the UK, providing a multidisciplinary range of testing services to both the NHS and Independent Healthcare sectors. TDL's laboratories are CPA accredited in all disciplines. Its main laboratory is based in central London, with smaller laboratories strategically positioned throughout the UK. These laboratories provide pathology services to hospitals, laboratories and clinical practice, and are supported by their own distribution and logistics network. For more information, visit www.tdlpathology.com.

SOURCE Ariosa Diagnostics; The Doctors Laboratory



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES